Hayashi, T., Fukui, T., Nakanishi, N., Yamamoto, S., Tomoyasu, M., Osamura, A., . . . Hirano, T. (2017). Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: Comparison with sitagliptin. Cardiovasc Diabetol.
Chicago Stili AlıntıHayashi, Toshiyuki, et al. "Dapagliflozin Decreases Small Dense Low-density Lipoprotein-cholesterol and Increases High-density Lipoprotein 2-cholesterol in Patients With Type 2 Diabetes: Comparison With Sitagliptin." Cardiovasc Diabetol 2017.
MLA AlıntıHayashi, Toshiyuki, et al. "Dapagliflozin Decreases Small Dense Low-density Lipoprotein-cholesterol and Increases High-density Lipoprotein 2-cholesterol in Patients With Type 2 Diabetes: Comparison With Sitagliptin." Cardiovasc Diabetol 2017.